Alvotech (NasdaqGM:ALVO) Update / Briefing Transcript
2025-12-16 18:02
Alvotech (NasdaqGM:ALVO) Update / Briefing December 16, 2025 12:00 PM ET Company ParticipantsLinda Jónsdóttir - CFORobert Wessman - Founder and Chairman of the BoardJoseph McClellan - COOOperatorDon't stop there. The COO, Joseph McClellan, and the Head of Investor Relations, which is Patrik Ling. There is one page in the presentation with the convertible bond terms. We can go through that afterwards. There must also be a Q&A session, and you can write your questions into the box on the top there. But now I ...
Neurocrine Biosciences (NasdaqGS:NBIX) 2025 R&D Day Transcript
2025-12-16 18:00
Neurocrine Biosciences (NasdaqGS:NBIX) 2025 R&D Day December 16, 2025 12:00 PM ET Speaker0Good morning and good afternoon. My name is Todd Tushla. I'm the Vice President of Investor Relations at Neurocrine Biosciences, and on behalf of our entire company, welcome to our 2025 R&D Day. Whether you're here in person, on the webcast, or reading the transcript, we're grateful for your time. We will be making forward-looking statements today to refer you to our latest SEC disclosures. Our speakers for today from ...
Affirm (NasdaqGS:AFRM) Fireside Chat Transcript
2025-12-16 18:02
Affirm (NasdaqGS:AFRM) Fireside Chat December 16, 2025 12:00 PM ET Company ParticipantsRob O'Hare - CFOConference Call ParticipantsMatt Cotes - AnalystMatt CotesEverybody, trickle in here for a second before we start. Okay, awesome, so my name's Matt Cotes. I work at Truist Securities, covering Payments and Fintech, and I'm really pleased to be joined by Rob O'Hare here. Rob has been with the firm for a little bit over five years now, and he's been in his current seat as CFO for a little bit over one year. ...
Sanofi (NasdaqGS:SNY) Update / Briefing Transcript
2025-12-16 17:17
Sanofi (NasdaqGS:SNY) Update / Briefing December 16, 2025 11:15 AM ET Company ParticipantsLouisa Hector - Head of Global Pharma Equity ResearchThomas Kudsk Larsen - Head of Investor RelationsSachin Jain - VPSarita Kapila - Co-Head European Pharmaceuticals Equity ResearchSimon Baker - Head of Global Biopharma ResearchNone - Company RepresentativeJames Quigley - Executive DirectorGraham Parry - Managing Director and Head of European Pharmaceuticals Biotechnology Equity ResearchJean-François Toussaint - Global ...
Ark Restaurants(ARKR) - 2025 Q4 - Earnings Call Transcript
2025-12-16 17:02
Ark Restaurants (NasdaqGM:ARKR) Q4 2025 Earnings Call December 16, 2025 11:00 AM ET Company ParticipantsAnthony Sirica - President and CFOMichael Weinstein - Chairman and CEOConference Call ParticipantsJeffrey Kaminsky - Research AnalystOperatorGreetings and welcome to Ark Restaurants' Fourth Quarter and Year-End 2025 Results Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. If anyone should require operator assistance during t ...
Cisco Systems(CSCO) - 2025 FY - Earnings Call Transcript
2025-12-16 17:02
Cisco Systems (NasdaqGS:CSCO) FY 2025 Annual General Meeting December 16, 2025 11:00 AM ET Company ParticipantsStefan Padfield - Executive Director of Free Enterprise ProjectSami Badri - Head of Investor RelationsEvan Sloves - SecretaryChuck Robbins - Chair and CEOSami BadriGood morning, ladies and gentlemen. Welcome to Cisco's 2025 Annual Meeting of Stockholders. This is Sami Badri, Head of Investor Relations, and I'm joined by Chuck Robbins, our Chair and CEO, and Evan Sloves, Secretary of the Company. Th ...
Cisco Systems(CSCO) - 2025 FY - Earnings Call Transcript
2025-12-16 17:02
Cisco Systems (NasdaqGS:CSCO) FY 2025 Annual General Meeting December 16, 2025 11:00 AM ET Company ParticipantsStefan Padfield - Executive Director of Free Enterprise ProjectSami Badri - Head of Investor RelationsEvan Sloves - SecretaryChuck Robbins - Chair and CEOSami BadriGood morning, ladies and gentlemen. Welcome to Cisco's 2025 Annual Meeting of Stockholders. This is Sami Badri, Head of Investor Relations, and I'm joined by Chuck Robbins, our Chair and CEO, and Evan Sloves, Secretary of the Company. Th ...
Ark Restaurants(ARKR) - 2025 Q4 - Earnings Call Transcript
2025-12-16 17:02
Ark Restaurants (NasdaqGM:ARKR) Q4 2025 Earnings Call December 16, 2025 11:00 AM ET Company ParticipantsMichael Weinstein - Chairman and CEOChristopher Love - SecretaryAnthony Sirica - President and CFOConference Call ParticipantsJeffrey Kaminsky - Research AnalystOperatorGreetings and welcome to Ark Restaurants' fourth quarter and year-end 2025 results call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. If anyone should require ...
Cisco Systems(CSCO) - 2025 FY - Earnings Call Transcript
2025-12-16 17:00
Cisco Systems (NasdaqGS:CSCO) FY 2025 Annual General Meeting December 16, 2025 11:00 AM ET Speaker0Good morning, ladies and gentlemen. Welcome to Cisco's 2025 Annual Meeting of Stockholders. This is Sami Badri, Head of Investor Relations, and I'm joined by Chuck Robbins, our Chair and CEO, and Evan Sloves, Secretary of the Company. The matters we'll be discussing today include forward-looking statements, which are subject to the risks and uncertainties that we discussed in detail in our documents filed with ...
Neurocrine Biosciences (NasdaqGS:NBIX) 2025 Earnings Call Presentation
2025-12-16 17:00
December 16, 2025 1 Forward-Looking Statements Neurocrine Biosciences R&D Day 2025 In addition to historical facts, this presentation contains forward-looking statements that involve a number of risks and uncertainties. These statements include, but are not limited to, statements related to: our business strategy, objectives, and future development plans; the benefits to be derived from our products and product candidates; the value our products and/or our product candidates may bring to patients; the conti ...